Centers for Disease Control and Prevention - ERA

Description

This FOA is to develop, improve, and implement laboratory techniques to assess babies born with severe combined immune deficiency (SCID) and other primary immunodeficiencies using next generation sequencing technologies as a second tier test in state newborn screening aboratories. CDC seeks to evaluate the potential of using next generation sequencing technologies in the state newborn screening laboratory setting. Results of this activity will be used to inform other state newborn screening laboratories about the feasibility of using next generation sequencing technologies in the state newborn screening laboratory setting to evaluate babies that screen positive for SCID and other primary mmunodeficiencies. The ultimate goal is to improve treatment outcomes for babies with SCID or other primary immunodeficiencies.

Who can apply

• Others

Contact

CDC Technical Information Management Section (TIMS) <br/>Procurement and Grants Office <br/>Telephone 770-488-2700 <br/>Email: PGOTIM@cdc.gov <br/>Hours: Monday - Friday, 7am – 4:30pm U.S. Eastern Standard Time
pgotim@cdc.gov